GlycoSyn is a world-leading CDMO in complex chemistry, with deep expertise in polymers, lipids, carbohydrates, and other challenging molecular structures. For over 20 years, we’ve been committed to advancing the development of life-changing medicines. Our proven expertise in chemical route design, analytical and process development, and current Good Manufacturing Practice (cGMP) enables us to support your product journey from early concept through to clinical supply. We turn complex chemistry into commercial success —at any scale. Our high-trust, transparent partnerships span from NASDAQ-listed pharmaceutical companies to fast-growing biotech start-ups. With a distinguished track record in drug development and regulatory submission, we help de-risk your Chemistry, Manufacturing, and Controls (CMC) programs. Our team of friendly experts combines scientific excellence with a deep understanding of regulatory requirements. We’re committed to safeguarding your product’s quality—and your intellectual property—every step of the way.
Looking for a particular GlycoSyn employee's phone or email?
The GlycoSyn annual revenue was $10.7 million in 2026.
Anushka Jayasuriya is the Director, Business Development and Partnerships of GlycoSyn.
10 people are employed at GlycoSyn.
GlycoSyn is based in Lower Hutt, Wellington.
The NAICS codes for GlycoSyn are [31, 3254, 32, 325, 311, 32541].
The SIC codes for GlycoSyn are [202, 283, 20, 28].